Combining Salmonella vaccines and the use of probiotics In livestock, the use of live microorganisms has become a hot topic in veterinary medicine and animal health. Increasingly, live microorganisms are being used to improve gut health and reduce antibiotic use, while at the same time, vaccination programs against enteric pathogens are being maintained or expanded. The big question is obvious: is everything that is beneficial individually also beneficial when applied together?
To answer that, we need to go beyond marketing slogans and review How vaccines and probiotics actually workThis article will examine what has been demonstrated in experimental studies (including models with paratuberculosis) and what practical factors influence product compatibility. We will calmly break down all this information, applying it to the realities of animal production, especially in ruminants and poultry, and emphasizing the importance of evaluating each combination within its specific context.
What are probiotics and why have they gained so much prominence?
Probiotics are defined, according to the FAO and WHOThese are live microorganisms that, when administered in adequate amounts, confer a health benefit to the host. In ruminants and poultry, they are considered one of the major alternatives to the use of antibiotics as performance enhancers, which aligns perfectly with current demands for antimicrobial reduction.
In ruminants, interest has skyrocketed because these products can increase productivity and strengthen the health system In general, instead of acting directly like a classic drug, they modulate the microbial ecosystem of the digestive tract, promoting a balance of beneficial flora and displacing potentially pathogenic microorganisms.
Its mode of action can be summarized in two main ways: on the one hand, the competitive exclusion of pathogensThat is, they compete for space and nutrients in the intestinal mucosa; on the other hand, they have the ability to directly stimulate immune cells, especially those associated with mucosal tissues, such as intestinal lymphoid tissue. This results in changes in cytokine production, neutrophil and macrophage activity, and antibody response.
Furthermore, in recent years the idea of ​​using probiotics as adjuvants or modulators of the vaccine responsecombining them with vaccines to try to boost their effectiveness. On paper, it sounds very appealing: a product that, in addition to improving gut health, amplifies the protection induced by vaccination. However, the immunological reality is more complex.
How vaccines work against Salmonella and other enteric pathogens
Vaccines used to control pathogens such as Salmonella or Mycobacterium avium subsp. paratuberculosis (MAP, the agent of paratuberculosis) seek to train the immune system to respond more quickly and effectively when the animal is exposed to the actual microorganism. They can be inactivated (dead) or live attenuated, and its design determines the type of response obtained.
In the case of inactivated paratuberculosis vaccines, it has been shown that they are capable of inducing a powerful humoral response (production of specific antibodies). But in addition, studies have revealed profound changes in the innate response: a clear training of neutrophils has been observed, which respond more intensely both to Map and to other different pathogens (heterologous response).
These vaccines can also activate macrophages present in the gut-associated lymphoid tissue (GALT)This generates an increased production of pro-inflammatory cytokines that help contain and reduce the bacterial load. In experimental models, this activation correlates with a decrease in the presence of Map in the GALT, a key indicator of efficacy against infection.
When we think about vaccination against Salmonella in birds or ruminants, the goal is similar: to achieve a balance in which the antibody response and cellular immunity, combined with trained innate immunity, allow reduce intestinal colonization and the excretion of bacteria, and with it the health and zoonotic risk.
Compatibility between probiotics and vaccines: what the research says
The theory that Probiotics and vaccines enhance each other This has spurred numerous studies. However, not all combinations work as expected. A very illustrative example comes from a study conducted in an Animal Health Department that evaluated a probiotic bacterium of the genus Dietzia in a model of Map infection in rabbits.
This study compared three different situations: administration of the probiotic only, the inactivated vaccination against paratuberculosis aloneand the combination of vaccine plus probiotic. Subsequently, all animals faced an infection challenge with Map to assess actual protection.
Vaccination alone produced an intense humoral response, trained the neutrophils in response to both homologous (Map) and heterologous stimuli, and stimulated the synthesis of pro-inflammatory cytokines in intestinal macrophagesFurthermore, it clearly reduced the Map load in the GALT, indicating a relevant protective effect against infection.
When the probiotic was administered after vaccination, the results were much more nuanced: an antibody response and a low bacterial load were maintained, similar to that of the vaccinated animals only, but the probiotic was observed to have a positive effect. It did not increase neutrophil activityIt increased metabolic demand and, most notably, suppressed the production of pro-inflammatory cytokines. In other words, it modulated the immune response towards a less inflammatory profile.
The situation was even less favorable when the probiotic was administered alone. In the absence of a vaccine, the probiotic bacteria failed to take effect. neither increase the humoral response nor the activity of neutrophilsAnd the Map load in the GALT was even higher than in the infected control group without any treatment. This suggests that, in this specific model, the probiotic alone not only does not protect, but may be associated with poorer infection control.
The main conclusion of the study is clear: this probiotic strain was able to significantly modify immune response pathways Activated by vaccination and infection, these antibodies can even hinder the proper elimination of the pathogen and impair neutrophil function. Therefore, it cannot be assumed that any probiotic will always be a positive "extra" when used alongside a vaccine.
Why probiotic-vaccine compatibility cannot be generalized
These types of results highlight that the compatibility between vaccines (including those for Salmonella) and probiotics is highly context-dependentIt depends on the animal species, the pathogen, the type of vaccine, and, of course, the probiotic strain and its dosage. What works in one combination may not work, or may even be harmful, in another.
From an immunological point of view, a probiotic can modulate the response in many ways: it can promote tolerance In response to certain stimuli, the body can reduce chronic inflammation or shift the response towards a different profile (for example, more regulatory and less pro-inflammatory). This can be very beneficial in processes of excessive inflammation, but detrimental if the goal is a strong response to control a resistant intracellular pathogen.
In the specific case of Salmonella and other enteropathogens, the balance between inflammation is necessary to eliminate the microorganism And the control of tissue damage is very delicate. A probiotic that reduces inflammation too much can decrease the host's ability to clear the infection, even if it reduces certain clinical signs in the short term.
Therefore, the importance of is emphasized experimentally verify each combination of vaccine and probiotic before recommending their routine use. It is not enough to have separate safety and efficacy data; it is necessary to evaluate what happens when they are administered together, in the same health program and under the same field conditions or in robust experimental models.
In productive species such as ruminants and poultry, where health decisions have direct impact on profitabilityIt is essential that these evaluations be done as objectively as possible and not solely on the basis of marketing arguments or anecdotal experiences.
Experience in poultry farming: probiotics, vaccines, and the right supplier
In the poultry sector, disease prevention through the use of vaccines and probiotics is of paramount importance. Meat and egg production takes place in a context where the health and economic risks They are high, and failures in biosecurity or sanitation can result in significant losses.
Before purchasing a Salmonella vaccine or an intestinal probiotic for chickens, the producer's mindset is increasingly resembling that of a demanding consumer of any other technological product: they value not only the technical characteristics, but also the brand credibility, delivery logistics, technical support and after-sales serviceJust as when buying a television you compare models, warranties and opinions of other users, in poultry farming you scrutinize the suppliers who will provide such sensitive products as vaccines and probiotics.
In this context, it is considered key that the supplier company offers a Proposed solutions with true expertiseThe service must be supported by professionals with experience in the poultry sector, who have in-depth knowledge of the production system, management practices, the most common diseases, and the practical limitations of daily farm operations. Only in this way is it possible to design coherent health programs that consider the potential interactions between vaccines and probiotics.
The safety and quality of biological products are other essential pillars. A vaccine or a probiotic must be free of contaminants and comply with strict quality control standards. To guarantee this, it is essential that the supplier has a biological testing laboratory capable of confirming the absence of unwanted microorganisms and verifying the potency and stability of each batch.
Furthermore, it is essential that companies support their products in serious research workDeveloped in collaboration with universities and independent institutions. The trials in vivoPerformance studies and pathogen challenge tests provide concrete data on efficacy, recommended dosage, product compatibility, and potential limitations. It's not just about saying something works, but about demonstrating it with figures and transparent methodology.
The role of the R&D laboratory in product compatibility
Companies that maintain a strong research and development (R&D) department are usually in a better position to launch new solutionsThis includes improving probiotic strains, optimizing vaccine formulations, and, above all, studying the compatibility between different products within the portfolio. This is especially important in the area of ​​vaccine-probiotic interactions.
A well-equipped R&D laboratory does not just develop new products; it also conducts tests vitro y in vivo To answer specific customer questions: Is this probiotic compatible with this oral vaccine? Is there a time interval between administrations? Does the antibody response change if they are used simultaneously? All these aspects can be scientifically evaluatedavoiding decisions based solely on intuition.
In the words of market intelligence and marketing specialists in the sector, a The R&D laboratory is crucial This is to resolve compatibility issues, adjust protocols, and offer producers solid technical support. This is especially important when working with vaccines against Salmonella or other enteric agents, which are often part of complex programs along with other biological products and additives.
The focus on innovation should not be limited to the development of new strains; it also includes the creation of practical solutions geared towards the day-to-day running of the farm: adapted presentation formats, simple administration schemes, clear conservation and handling protocols, and monitoring tools to evaluate actual effectiveness in the field.
In addition, a well-trained technical support team is crucial. It's not very useful to have great products if, when it comes down to it, the producer doesn't receive the support they need. professional support after purchaseAnswering questions, interpreting production and health results, and adapting vaccination and probiotic programs to changes in the farm are tasks that require experienced personnel.
In terms of logistics, poultry production is subject to very rigid schedules. It is essential that the supplier can to guarantee timely deliveries and in suitable condition of transport and storage, to avoid stockouts that would force the interruption of vaccine or probiotic use. A failure at this point can compromise not only a batch, but the sanitary stability of the entire system.
Finally, the relationship between producer and supplier must be based on the reliability and transparencyOpen communication about product limitations, potential interactions, and actual field results strengthens trust and enables informed decisions in the medium and long term.
In this sense, some companies in the sector, such as Biocamp, position themselves as strategic suppliers They combine an experienced technical team, an active R&D laboratory, and a clear commitment to innovation and customer support. This type of comprehensive approach is especially valuable when dealing with products that directly affect health and performance, such as vaccines and probiotics.
All this information demonstrates that the Salmonella vaccine and probiotic compatibility This is not a minor issue, nor something that can be resolved with a simple standard recommendation. It requires a thorough understanding of the immune mechanisms involved, a review of the results of experimental studies where specific combinations have been tested, and support from suppliers with the technical and R&D capabilities to evaluate each case. Only in this way can the potential of probiotics be harnessed without compromising the efficacy of vaccines or the animal's ability to control infections as sensitive as those caused by Salmonella or MAP.